+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global AI-based Clinical Trials Market by Component (Services, Software), Function (Adverse Event Detection, Data Collection & Analysis, Patient Recruitment & Screening), Phase, Technology, Application, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5437793
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The AI-based Clinical Trials Market size was estimated at USD 6.52 billion in 2023, USD 7.73 billion in 2024, and is expected to grow at a CAGR of 18.79% to reach USD 21.79 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the AI-based Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the AI-based Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the AI-based Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Aiforia Technologies Oyj, Antidote Technologies, Inc., Ardigen S.A., Avantor, Inc., BioAge Labs, BioSymetrics Inc., Deep 6 AI Inc., Envisagenics, Euretos Services BV, Exscientia PLC, GNS Healthcare, Google LLC by Alphabet Inc., Innoplexus AG, InSilico Medicine, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Median Technologies, Nuritas Limited, Pharmaceutical Pipeline Enhancement Strategies, LLC, Saama Technologies, Inc., Symplr Software LLC, Trials.ai, Inc. by ZS Associates, Inc., and Unlearn.AI, Inc.

Market Segmentation & Coverage

This research report categorizes the AI-based Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Services
    • Software
  • Function
    • Adverse Event Detection
    • Data Collection & Analysis
    • Patient Recruitment & Screening
    • Predictive Modeling
    • Trial Design & Optimization
  • Phase
    • Phase-I
    • Phase-II
    • Phase-III
  • Technology
    • Machine Learning
    • Natural Language Processing
  • Application
    • Cardiovascular Diseases
    • Infectious Diseases
    • Metabolic Diseases
    • Neurological Diseases
    • Oncology
  • End-user
    • Academic & Research Institutes
    • Contract Research Organization
    • Hospitals
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the AI-based Clinical Trials Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the AI-based Clinical Trials Market?
  3. What are the technology trends and regulatory frameworks in the AI-based Clinical Trials Market?
  4. What is the market share of the leading vendors in the AI-based Clinical Trials Market?
  5. Which modes and strategic moves are suitable for entering the AI-based Clinical Trials Market?

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. AI-based Clinical Trials Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for artificial Intelligence which helps in boosting and improving clinical trials
5.1.1.2. Rising needs to reduce healthcare costs and declining hardware costs
5.1.1.3. Increased adoption of AI-based drug development technology by most of the pharmaceutical companies
5.1.2. Restraints
5.1.2.1. Lack of personal involvement leading to a rise in unemployment rates
5.1.2.2. Possibility of a defective diagnosis
5.1.3. Opportunities
5.1.3.1. Technological advancements and innovations in AI-based clinical trials
5.1.3.2. Major pharmaceutical companies are ensuring more joint ventures and partnerships with AI vendors
5.1.4. Challenges
5.1.4.1. Concerns associated with the adoption of EHR interoperability
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. AI-based Clinical Trials Market, by Component
6.1. Introduction
6.2. Services
6.3. Software
7. AI-based Clinical Trials Market, by Function
7.1. Introduction
7.2. Adverse Event Detection
7.3. Data Collection & Analysis
7.4. Patient Recruitment & Screening
7.5. Predictive Modeling
7.6. Trial Design & Optimization
8. AI-based Clinical Trials Market, by Phase
8.1. Introduction
8.2. Phase-I
8.3. Phase-II
8.4. Phase-III
9. AI-based Clinical Trials Market, by Technology
9.1. Introduction
9.2. Machine Learning
9.3. Natural Language Processing
10. AI-based Clinical Trials Market, by Application
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Infectious Diseases
10.4. Metabolic Diseases
10.5. Neurological Diseases
10.6. Oncology
11. AI-based Clinical Trials Market, by End-user
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organization
11.4. Hospitals
11.5. Pharmaceutical & Biopharmaceutical Companies
12. Americas AI-based Clinical Trials Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific AI-based Clinical Trials Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa AI-based Clinical Trials Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. AiCure, LLC
16.1.2. Aiforia Technologies Oyj
16.1.3. Antidote Technologies, Inc.
16.1.4. Ardigen S.A.
16.1.5. Avantor, Inc.
16.1.6. BioAge Labs
16.1.7. BioSymetrics Inc.
16.1.8. Deep 6 AI Inc.
16.1.9. Envisagenics
16.1.10. Euretos Services BV
16.1.11. Exscientia PLC
16.1.12. GNS Healthcare
16.1.13. Google LLC by Alphabet Inc.
16.1.14. Innoplexus AG
16.1.15. InSilico Medicine
16.1.16. Intel Corporation
16.1.17. International Business Machines Corporation
16.1.18. Koninklijke Philips N.V.
16.1.19. Median Technologies
16.1.20. Nuritas Limited
16.1.21. Pharmaceutical Pipeline Enhancement Strategies, LLC
16.1.22. Saama Technologies, Inc.
16.1.23. Symplr Software LLC
16.1.24. Trials.ai, Inc. by ZS Associates, Inc.
16.1.25. Unlearn.AI, Inc.
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. AI-BASED CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. AI-BASED CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. AI-BASED CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AI-BASED CLINICAL TRIALS MARKET DYNAMICS
FIGURE 7. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
FIGURE 10. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 12. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 14. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. AI-BASED CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. AI-BASED CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. AI-BASED CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. AI-BASED CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AI-BASED CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. AI-BASED CLINICAL TRIALS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. AI-BASED CLINICAL TRIALS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 9. AI-BASED CLINICAL TRIALS MARKET SIZE, BY ADVERSE EVENT DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. AI-BASED CLINICAL TRIALS MARKET SIZE, BY DATA COLLECTION & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PATIENT RECRUITMENT & SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TRIAL DESIGN & OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 15. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE-I, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE-II, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE-III, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. AI-BASED CLINICAL TRIALS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AI-BASED CLINICAL TRIALS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. AI-BASED CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AI-BASED CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AI-BASED CLINICAL TRIALS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AI-BASED CLINICAL TRIALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AI-BASED CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AI-BASED CLINICAL TRIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AI-BASED CLINICAL TRIALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AI-BASED CLINICAL TRIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 53. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 54. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MEXICO AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 85. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 86. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CHINA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 90. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 91. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 92. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 102. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 103. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. JAPAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 138. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 139. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. THAILAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 156. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 157. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 158. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. DENMARK AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 163. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. EGYPT AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 169. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 175. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 181. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. GERMANY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 193. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 194. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 195. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. ITALY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 211. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 217. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 218. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 219. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 223. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 224. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 225. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. QATAR AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 247. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 248. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SPAIN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 265. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 266. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. TURKEY AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM AI-BASED CLINICAL TRIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. AI-BASED CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 283. AI-BASED CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. AI-BASED CLINICAL TRIALS MARKET LICENSE & PRICING

Companies Mentioned

  • AiCure, LLC
  • Aiforia Technologies Oyj
  • Antidote Technologies, Inc.
  • Ardigen S.A.
  • Avantor, Inc.
  • BioAge Labs
  • BioSymetrics Inc.
  • Deep 6 AI Inc.
  • Envisagenics
  • Euretos Services BV
  • Exscientia PLC
  • GNS Healthcare
  • Google LLC by Alphabet Inc.
  • Innoplexus AG
  • InSilico Medicine
  • Intel Corporation
  • International Business Machines Corporation
  • Koninklijke Philips N.V.
  • Median Technologies
  • Nuritas Limited
  • Pharmaceutical Pipeline Enhancement Strategies, LLC
  • Saama Technologies, Inc.
  • Symplr Software LLC
  • Trials.ai, Inc. by ZS Associates, Inc.
  • Unlearn.AI, Inc.

Methodology

Loading
LOADING...

Table Information